Another very promising target for the treatment of pancreatic cancer is the Hedgehog signaling pathway. Currently, a large body of research is focused on modulating solid tumor stem cells as a means to selectively target malignant disease. This strategy is dependent upon the hypothesis that a small, discrete population of stem cells is present in solid tumors that posses an immortal self-renewal capacity with the potential for diverse differentiation. Regulation of cancer stem cells is modulated by a group of signaling molecules with important functions in embryonic development; these include Hedgehog, Notch, Wnt, and bone morphogenic protein/transforming growth factor-β (BMP/TGF-β). Altered regulation of these proteins may occur in a variety of cancer types. One target with particular promise for treating pancreatic cancer is the Hedgehog (Hh) signaling pathway (1, 2).
The Hedgehog signaling pathway is comprised of three creatively named secretory proteins, Sonic Hedgehog (SHH), Indian Hedgehog (IHH), and Desert Hedgehog (DHH). All can modulate cell-cell signaling and are involved in the control of tissue formation or “patterning” during normal embryonic development ( 2 ). In some systems, activation of Hh signaling promotes cell proliferation, whereas in others it can induce differentiation. In tumor cells, aberrant Hh signaling may contribute to the expression of an aggressive malignant phenotype. Recently, it has been a focus for new therapeutic strategies for treating various cancers, including pancreatic tumors ( 3 ).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Evangelista M, Tian H, de Sauvage FJ. The hedgehog signaling pathway in cancer. Clin Cancer Res 2006, 12:5924–8.
Rubin LL, de Sauvage FJ, 2006, Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov 5:1026–1033.
Kayed H, Kleeff J, Osman T, 2006, Hedgehog signaling in the normal and diseased pancreas. Pancreas 32:119–129.
Roessler E, Belloni E, Gaudenz K, 1997, Mutations in the C-terminal domain of Sonic Hedgehog cause holoprosencephaly. Hum Mol Genet 6:1847–1853.
Pathi S, Pagan-Westphal S, Baker DP, 2001, Comparative biological responses to human Sonic, Indian, and Desert hedgehog. Mech Dev 106:107–117.
Sacedon R, Varas A, Hernandez-Lopez C, 2003, Expression of hedgehog proteins in the human thymus. J Histochem Cytochem 51:1557–1566.
Kayed H, Kleeff J, Esposito I, 2005, Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas. Mol Carcinog 42:183–192.
Gorlin RJ, 2004, Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 6:530–539.
Lindstrom E, Shimokawa T, Toftgard R, 2006, PTCH mutations: distribution and analyses. Hum Mutat 27:215–219.
Adolphe C, Hetherington R, Ellis T, 2006, Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res 66:2081–2088.
Watkins DN, Berman DM, Baylin SB, 2003, Hedgehog signaling: progenitor phenotype in small-cell lung cancer. Cell Cycle 2:196–198.
Watkins DN, Berman DM, Burkholder SG, 2003, Hedgehog signalling within airway epithe-lial progenitors and in small-cell lung cancer. Nature 422:313–317.
Berman DM, Karhadkar SS, Maitra A, 2003, Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425:846–851.
Pasca di Magliano M, Sekine S, Ermilov A, 2006, Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev 20:3161–3173.
Feldmann G, Dhara S, Fendrich V, 2007, Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 67:2187–2196.
Ji Z, Mei FC, Xie J, 2007, Oncogenic kras suppresses GLI1 degradation and activates hedge-hog signaling pathway in pancreatic cancer cells. J Biol Chem 278:38254–38259.
Williams JA, Guicherit OM, Zaharian BI, 2003, Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci U S A 100:4616–4121.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Takimoto, C.H. (2008). Novel Targets for the Treatment of Pancreatic Cancer II: The Hedgehog Signaling Pathway. In: Lowy, A.M., Leach, S.D., Philip, P.A. (eds) Pancreatic Cancer. M. D. Anderson Solid Tumor Oncology Series. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-69252-4_40
Download citation
DOI: https://doi.org/10.1007/978-0-387-69252-4_40
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-69250-0
Online ISBN: 978-0-387-69252-4
eBook Packages: MedicineMedicine (R0)